Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fatak Chemie Pars Pharmacy
Tehran, Tehran, Iranfcp-pharma.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Fatak Chemie Pars (FCP) is an Iranian pharmaceutical company specializing in the development and production of active pharmaceutical ingredients (APIs) and finished dosage forms. Founded in 2003, the company operates a manufacturing facility in the Eshtehard Industrial Town that complies with international Good Manufacturing Practice (GMP) standards. FCP's product portfolio primarily focuses on generic small molecule therapeutics for chronic conditions, including diabetes, epilepsy, and cardiovascular diseases. The company serves as both a manufacturer of finished drugs and a supplier of chemical raw materials for the broader pharmaceutical industry in the region.
- Therapeutic areas
- EndocrinologyNeurologyCardiovascular
- Modalities
- Small molecule
- Industry
- Pharma
Beyond the preview
Go deeper on Fatak Chemie Pars Pharmacy.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Fatak Chemie Pars Pharmacy.